| UniProt/SwissProt ID: | HNRPK_HUMAN |
| Description: | heterogeneous nuclear ribonucleoprotein K [Source:HGNC Symbol;Acc:5044] |
| Location: | chr9 q21.32 |
| Node attribute: | substrate; TF |
| Phosphorylation site |
| Position | PhosphoPeptide | Catalytic kinase | Source |
|---|---|---|---|
| S214 | ILDLIsESPIK | Phi-29_GP3 | PhosphoSitePlus |
| Y458 | NSVKQySGKFF | PhosphoSitePlus | |
| S141 | QHYKGsDFDCE | PhosphoSitePlus | |
| S77 | YNASVsVPDSS | KH_1 | PhosphoSitePlus |
| S302 | GGRGGsRARNL | PKCd | RegPhos |
| Y373 | GYDYSyAGGRG | PhosphoSitePlus | |
| Y236 | DETYDyGGFTM | Src | RegPhos |
| T3 | METEQpEE | RegPhos | |
| S216 | DLISEsPIKGR | JNK3(MAPK10 | RegPhos |
| Y236 | DETYDyGGFTM | SRC | HPRD; phosphoELM; RegPhos |
| S302 | GGRGGsRARNL | PRKCD | HPRD |
| S302 | GGRGGsRARNL | PKC_delta | phosphoELM |
| S420 | HESGAsIKIDE | HPRD | |
| T120 | PSPTAtSQLPL | PhosphoSitePlus; HPRD; phosphoELM | |
| Y234 | FYDETyDYGGF | SRC | HPRD; phosphoELM; RegPhos |
| S127 | QLPLEsDAVEC | HPRD | |
| S353 | AIDTWsPSEWQ | JNK3(MAPK10 | RegPhos |
| S284 | DYDDMsPRRGP | PKC_delta | phosphoELM |
| S302 | GGRGGsRARNL | PKCd(PKC delta | RegPhos |
| Y236 | DETYDyGGFTM | Phi-29_GP3 | PhosphoSitePlus |
| Y323 | GDLMAyDRRGR | PhosphoSitePlus | |
| Y230 | YDPNFyDETYD | Phi-29_GP3 | PhosphoSitePlus |
| S353 | AIDTWsPSEWQ | MAPK3 | phosphoELM |
| Y230 | YDPNFyDETYD | SRC | HPRD; phosphoELM; RegPhos |
| Y72 | ALRTDyNASVS | SRC | HPRD; RegPhos |
| S284 | DYDDMsPRRGP | MAPK10 | HPRD |
| S284 | DYDDMsPRRGP | PKCd(PKC delta | RegPhos |
| S353 | AIDTWsPSEWQ | Erk1(MAPK3 | RegPhos |
| S379 | AGGRGsYGDLG | PhosphoSitePlus; HPRD; phosphoELM; RegPhos | |
| T440 | ITITGtQDQIQ | KH_1 | PhosphoSitePlus |
| S216 | DLISEsPIKGR | MAPK10 | HPRD; phosphoELM |
| S284 | DYDDMsPRRGP | PhosphoSitePlus; HPRD; phosphoELM; RegPhos | |
| S116 | GLQLPsPTATS | PhosphoSitePlus; HPRD; phosphoELM; RegPhos | |
| T39 | KRSRNtDEMVE | ROKNT | PhosphoSitePlus |
| S353 | AIDTWsPSEWQ | MAPK10 | HPRD; phosphoELM |
| S216 | DLISEsPIKGR | JNK3 | RegPhos |
| S36 | QAFKRsRNTDE | HPRD; phosphoELM; RegPhos | |
| S417 | QIRHEsGASIK | HPRD | |
| S284 | DYDDMsPRRGP | JNK3 | RegPhos |
| Y138 | LNYQHyKGSDF | PhosphoSitePlus | |
| S276 | RPMPPsRRDYD | PhosphoSitePlus | |
| T390 | GPIITtQVTIP | KH_1 | PhosphoSitePlus |
| Y225 | GRAQPyDPNFY | Phi-29_GP3 | PhosphoSitePlus |
| Y371 | GSGYDySYAGG | PhosphoSitePlus | |
| Y333 | RPGDRyDGMVG | PhosphoSitePlus | |
| Y234 | FYDETyDYGGF | Src | RegPhos |
| S121 | SPTATsQLPLE | PhosphoSitePlus | |
| S353 | AIDTWsPSEWQ | MAPK8 | phosphoELM |
| S353 | AIDTWsPSEWQ | JNK1(MAPK8 | RegPhos |
| S353 | AIDTWsPSEWQ | JNK3 | RegPhos |
| S372 | SGYDYsYAGGR | PhosphoSitePlus | |
| Y380 | GGRGSyGDLGG | Src | RegPhos |
| S214 | ILDLIsESPIK | HPRD; RegPhos | |
| T118 | QLPSPtATSQL | PhosphoSitePlus; HPRD; phosphoELM | |
| Y72 | ALRTDyNASVS | KH_1 | PhosphoSitePlus |
| Y380 | GGRGSyGDLGG | SRC | phosphoELM |
| Y280 | PSRRDyDDMSP | PhosphoSitePlus; HPRD | |
| S302 | GGRGGsRARNL | PhosphoSitePlus | |
| Y361 | EWQMAyEPQGG | PhosphoSitePlus | |
| Y380 | GGRGSyGDLGG | PhosphoSitePlus; HPRD; phosphoELM | |
| Y449 | IQNAQyLLQNS | KH_1 | PhosphoSitePlus |
| Y234 | FYDETyDYGGF | Phi-29_GP3 | PhosphoSitePlus |
| S154 | LLIHQsLAGGI | KH_1; Phi-29_GP3 | PhosphoSitePlus |
| Y230 | YDPNFyDETYD | Src | RegPhos |
| S353 | AIDTWsPSEWQ | PhosphoSitePlus; phosphoELM | |
| Y225 | GRAQPyDPNFY | SRC | HPRD; RegPhos |
| S216 | DLISEsPIKGR | Phi-29_GP3 | PhosphoSitePlus |
| T3 | ___MEtEQPEE | ROKNT | PhosphoSitePlus |
| S216 | DLISEsPIKGR | HPRD; phosphoELM; RegPhos | |
| S401 | KDLAGsIIGKG | HPRD | |
| S401 | KDLAGsIIGKG | KH_1 | PhosphoSitePlus |
| T3 | QPEE | HPRD; phosphoELM | |
| S284 | DYDDMsPRRGP | MAPK3 | phosphoELM |
| Y369 | QGGSGyDYSYA | PhosphoSitePlus | |
| Y135 | VECLNyQHYKG | PhosphoSitePlus; HPRD | |
| Dephosphorylation site |
| HNRPK_HUMAN do not have dephosphorylation site. |
| Mutation site |
| Ensembl ID | Variation | Source | Cancer name | Pubmed |
|---|---|---|---|---|
| ENSP00000365439 | G376D | COSMIC | Melanoma | |
| ENSP00000365458 | G376D | COSMIC | Melanoma | |
| ENSP00000365444 | G376D | COSMIC | Melanoma | |
| Differential expressed protein |
| Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
|---|---|---|---|---|---|---|
| ENSP00000365440 | Uterine Cancer | Normal vs. Cancer | tissue | Up | 17902640 | |
| ENSP00000365440 | Leukemia | Normal vs. Cancer | cell line | Down | 0.45 | 17022645 |
| ENSP00000365440 | Leukemia | Normal vs. Cancer | cell line | Down | 0.45 | 17022645 |
| ENSP00000365440 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Up | 9.9 | 19072117 |
| ENSP00000365440 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Up | 1.1 | 19072117 |
| ENSP00000365440 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Up | 1.1 | 19072117 |
| ENSP00000365440 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Up | 1.7 | 19072117 |
| ENSP00000365440 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Up | 1.2 | 19072117 |
| ENSP00000365440 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Up | 1.5 | 19072117 |
| ENSP00000365440 | Esophageal Cancer | Normal vs. Cancer | tissue | Down | 0.27 | 19142970 |
| ENSP00000365440 | hepatitis B virus | Treatment (none vs tetracycline-treatment) | cell line | Up | 2 | 19671925 |
| ENSP00000365440 | Non-small cell lung carcinoma | Treatment (none vs CIGB-300 treatment) | cell line | Down | 0.31 | 20804217 |
| ENSP00000365440 | Breast Cancer | Normal vs. Cancer | cell line | Down | 0.38 | 20052998 |
| ENSP00000365440 | Breast Cancer | Normal vs. Cancer | cell line | Down | 0.42 | 20052998 |
| ENSP00000365440 | Breast Cancer | Metastasis | cell line | Up | 1.2 | 20052998 |
| ENSP00000365440 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Down | 0.16 | 17655343 |
| ENSP00000365440 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Down | 17655343 | |
| ENSP00000365440 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Down | 0.34 | 17655343 |
| ENSP00000365440 | Neoplasms by Histologic Type | Cancer vs. Cancer (subtype) | tissue | Down | 0.56 | 16807943 |
| ENSP00000365440 | Neoplasms by Histologic Type | Cancer vs. Cancer (subtype) | tissue | Down | 0.61 | 16807943 |
| ENSP00000365440 | Biliary Tract Cancer | Metastasis | cell line | Up | 3.6 | 19299076 |
| Hyperphosphorylation site |
| HNRPK_HUMAN do not have hyperphosphorylation site. |
| Direct Interaction Pair |
| Source | Target | Relationship | Resource |
|---|---|---|---|
| KPCD_HUMAN | HNRPK_HUMAN | kinase -> substrate | HPRD; Robert H Newman (2013) |
| KPCL_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| PKN1_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| SRPK1_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| BTK_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| MK03_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| PDPK1_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| AKT1_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| KSYK_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| SCYL2_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| KPCZ_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| LCK_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| WEE1_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| MK10_HUMAN | HNRPK_HUMAN | kinase -> substrate | RegPhos; Robert H Newman (2013) |
| BMX_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| KS6B1_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CSK21_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CDK4_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| RET_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| KPCA_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| LYN_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| ZAGL2_HUMAN | HNRPK_HUMAN | kinase -> substrate | RegPhos |
| NEK3_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| SRC_HUMAN | HNRPK_HUMAN | kinase -> substrate | RegPhos |
| FAK2_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| FGR_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| MK08_HUMAN | HNRPK_HUMAN | kinase -> substrate | RegPhos; Robert H Newman (2013) |
| EPHB3_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CSK22_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| TYK2_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| GSK3B_HUMAN | HNRPK_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| HNRPK_HUMAN | MYC_HUMAN | TF -> target gene | TRANSFAC |
| Function Annotation |
| KEGG Pathway |
| KEGG ID | Pathway |
|---|---|
| hsa03040 | Spliceosome |
| hsa05203 | Viral carcinogenesis |
| hsa05168 | Herpes simplex infection |
| Gene Ontology |
| GO ID | GO_Term | Evidence | Ontology |
|---|---|---|---|
| GO:0005737 | cytoplasm | IEA | cellular_component |
| GO:0000398 | mRNA splicing, via spliceosome | IC | biological_process |
| GO:0005515 | protein binding | IPI | molecular_function |
| GO:0071013 | catalytic step 2 spliceosome | IDA | cellular_component |
| GO:0008380 | RNA splicing | TAS | biological_process |
| GO:0010467 | gene expression | TAS | biological_process |
| GO:0000978 | RNA polymerase II core promoter proximal region se | IMP | molecular_function |
| GO:0006396 | RNA processing | TAS | biological_process |
| GO:0005634 | nucleus | IDA | cellular_component |
| GO:0019048 | virus-host interaction | IEA | biological_process |
| GO:0003697 | single-stranded DNA binding | TAS | molecular_function |
| GO:0000790 | nuclear chromatin | IDA | cellular_component |
| GO:0005654 | nucleoplasm | TAS | cellular_component |
| GO:0045716 | positive regulation of low-density lipoprotein par | IMP | biological_process |
| GO:0005515 | protein binding | IEA | molecular_function |
| GO:0010988 | regulation of low-density lipoprotein particle cle | IMP | biological_process |
| GO:0001077 | RNA polymerase II core promoter proximal region se | IMP | molecular_function |
| GO:0048260 | positive regulation of receptor-mediated endocytos | IMP | biological_process |
| GO:0045944 | positive regulation of transcription from RNA poly | IMP | biological_process |
| GO:0072369 | regulation of lipid transport by positive regulati | IMP | biological_process |
| GO:0007165 | signal transduction | TAS | biological_process |
| GO:0003723 | RNA binding | IEA | molecular_function |